Clinical Trial

Fecal Microbiota Transplantation in Parkinson's Disease.

Study acronym: FMT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Fecal microbiota transplantation (FMT) is an effective and safe treatment for Clostridioides difficile infection (CDI). Though CDI is the only indication for FMT, more and more preliminary data on FMT in neurological disorders are reported due to gut-brain axis. This study is a pilot study to apply FMT on patients with Parkinson's disease (PD). The effect of FMT on motor and non-motor symptoms in PD will be also evaluated.
Trial Details
NCT Number NCT07597421
Lead Sponsor Chang Gung Memorial Hospital
Conditions Parkinson's Disease
Enrollment 58 participants
Start Date 2026-09-01
Primary Completion 2029-04-07 (estimated)
Study Completion 2029-04-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-19